Pfizer: A Reluctant Upgrade To Hold (NYSE:PFE)
I am a corporate lawyer with an MBA and a long-standing interest in value investing. After spending 7 years practicing at several prestigious Wall Street and Silicon Valley law firms as a corporate transactional lawyer, I founded and have been operating my own boutique law firm for the last 10 years, focusing on investment transactions and the resolution of investment disputes. I occasionally write here to clarify and organize my own thinking. My goals are twofold: (1) to identify reasonably priced companie ...